| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
LX-4211
|
1018899-04-1 |
LX4211
|
糖4211;(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(甲硫基)四氢-2H-吡喃-3,4,5-三醇;(2S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-;(2S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(甲基硫代)四氢-2H-吡喃-3,5-三醇
|
C21H25ClO5S |
424.9382 | |
|
OSU-03012
|
742112-33-0 |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺
|
N;AAR-12;OSU03012;OSU 03012;CS-1848;2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺;OSU-03012 (AR-12);N;AAR-12;OSU03012;OSU 03012
|
C26H19F3N4O |
460.46 | |
|
seliciclib
|
186692-46-6 |
细胞周期蛋白B激酶抑制剂
|
CYC202;R-ROSCOVITINE;SELICICLIB;P34 CDC2;细胞周期蛋白B激酶抑制剂;细胞周期蛋白B激酶抑制剂;6-(苄基氨基)-2(R)-[[1-(羟甲基)丙基]氨基]-9-异丙基嘌呤;SELICICLIB (ROSCOVITINE);CYC-203(ROSCOVITINE)
|
C19H26N6O |
354.45 | |
|
AZD 7545
|
252017-04-2 |
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羟基-2-甲基-1-氧代丙基]氨基]苯基]磺酰基]-N,N-二甲基苯甲酰胺
|
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羟基-2-甲基-1-氧代丙基]氨基]苯基]磺酰基]-N,N-二甲基苯甲酰胺;(R)-4-((3-氯-4-(3,3-三氟-2-羟基-2-甲基丙酰胺基)苯基)磺酰基)-N,N-二甲基苯甲酰胺;AZD 7547;AZD7547
|
C19H18ClF3N2O5S |
478.8698296 | |
|
VX 702
|
745833-23-2 |
6-[(氨基羰基)(2,6-二氟苯基)氨基]-2-(2,4-二氟苯基)-3-吡啶甲酰胺
|
2-(2,4-二氟苯基)-6-(1-[2,6-二氟苯基)脲基]烟酰胺;6-[(氨基羰基)(2,6-二氟苯基)氨基]-2-(2,4-二氟苯基)-3-吡啶甲酰胺;VX702;VX-702
|
C19H12F4N4O2 |
404.317793 | |
|
CCT007093
|
176957-55-4 |
(2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮
|
(2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮
|
C15H12OS2 |
272.38518 | |
|
Mps1-IN-2
|
1228817-38-6 |
9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-B][1,4]二氮杂卓-6(7H)-酮
|
9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino]-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one Mps1-in-2;Mps1-IN-2;Msp1-IN-2;9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino]-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one
|
|||
|
Pimecrolimus
|
137071-32-0 |
吡美莫司
|
吡美莫司;匹美克莫司;吡美莫司;匹美克莫司;匹美莫司;吡美莫司(匹美克莫司、吡美莫司、匹美莫司);吡美莫司杂质;PIMECROLIMUS吡美莫司
|
C43H68NO11Cl |
810.45312 | 603-999-7 |
|
OTSSP167
|
1431697-89-0 |
1-[6-(3,5-二氯-4-羟基苯基)-4-[[反式-4-[(二甲基氨基)甲基]环己基]氨基]-1,5-萘啶-3-基]-乙酮
|
CS-1832;1-[6-(3,5-二氯-4-羟基苯基)-4-[[反式-4-[(二甲基氨基)甲基]环己基]氨基]-1,5-萘啶-3-基]-乙酮
|
C25H28Cl2N4O2 |
487.42142 | 200-258-5 |
|
MLN9708
|
1201902-80-8 |
MLN978
|
枸橼酸艾沙佐米;埃沙佐米柠檬酸盐4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸;CS-1830;艾沙唑咪;MLN9708;MLN-9708;埃沙左米柠檬酸;艾沙佐米柠檬酸盐;MLN9708,20S蛋白酶体抑制剂
|
C20H23BCl2N2O9 |
517.12162 | |
|
WH-4-023
|
837422-57-8 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE
|
2,6-二甲基苯基 N-[2,4-二(甲氧基)苯基][2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基甲酸酯;DUAL LCK/SRC INHIBITOR;KIN001-112; KIN112
|
C32H36N6O4 |
568.68 | |
|
Tedizolid
|
856866-72-3 |
特地唑胺
|
(R)-3-(3-氟-4-(6-(2-甲基-2H-四唑-5-基)吡啶-3-基)苯基)-5-(羟甲基)恶唑烷-2-酮,特地唑胺;特地唑胺杂质7;CS-1826;TOREZOLID-21;泰地唑利;特地唑胺游离碱;磷酸特地唑胺TR-700;TEDIZOLID;TR-700;DA-7158
|
C17H15N6O3F |
370.3378 | 815-370-6 |
|
LMK-235
|
1418033-25-6 |
N-[[6-(羟基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺
|
N-[[6-(羟基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺;LMK235;LMK 235;CS-1820
|
C15H22N2O4 |
294.34618 | 808-770-7 |
|
Ascomycin
|
104987-12-4 |
长川霉素
|
FK520;FK 520;他克莫司 A;TACROLIMUS RELATED COMPOUND A (ASCOMYCIN);子囊霉素;8-乙基-3-(2-(4-羟基-3-甲氧环己基)-1-甲基乙烯基)-14,16-二甲烷;他克莫司USP RC A;子囊霉素:他克莫司-亚甲基杂质;子囊霉素(他克莫司相关化合物A);CS-1818
|
C43H69NO12 |
792.01 | 600-627-5 |
|
WS6
|
1421227-53-3 |
N-(6-(4-(2-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYLAMINO)-2-OXOETHYL)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE
|
|
C29H31F3N6O3 |
568.5900496 | |
|
MI-2 (Menin-MLL Inhibitor)
|
1271738-62-5 |
MI-2 (Menin-MLL Inhibitor)
|
5-二甲基-2-噻唑基)-1-哌嗪基]-6-丙基噻吩并[2;5-二氢-5;MI-2 5MG;MI-2,≥98%;4-(4-(5,5-二甲基-4,5-二氢噻唑-2-基)哌嗪-1-基)-6-丙基噻吩并[2,3-D]嘧啶;4-[4-(4,5-二氢-5,5-二甲基-2-噻唑基)-1-哌嗪基]-6-丙基噻吩并[2,3-D]嘧啶;MI2;MI-2;CS-1810
|
C18H25N5S2 |
375.5546 | |
|
MI-3 (Menin-MLL Inhibitor)
|
1271738-59-0 |
MI-3 (Menin-MLL Inhibitor)
|
4-[4-(4,5-二氢-5,5-二甲基-2-噻唑基)-1-哌嗪基]-6-异丙基噻吩并[2,3-D]嘧啶;CS-1809;MI3;MI 3;MENIN-MLL INHIBITOR 3;THIENO[2;3-D]PYRIMIDINE;4-[4-(4;5-DIHYDRO-5;5-DIMETHYL-2-THIAZOLYL)-1-PIPERAZINYL]-6-(1-METHYLETHYL)
|
C18H25N5S2 |
375.5546 | |
|
OSI-930
|
728033-96-3 |
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺
|
OSI-930;OSI930;CS-1804;噻尔非尼;3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺
|
C22H16F3N3O2S |
443.45 | |
|
WS3
|
1421227-52-2 |
N-(6-(4-(3-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE
|
重复
|
C28H30F3N7O3 |
569.5781096 | |
|
LED209
|
245342-14-7 |
N-苯基-4-(3-苯基硫代脲基)苯磺酰胺
|
N-苯基-4-(3-苯基硫代脲基)苯磺酰胺;N-苯基-4-[[(苯基氨基)硫代甲酰基]氨基]苯磺酰胺
|
C19H17N3O2S2 |
383.48718 |
药智官方微信
药智官方微博
